Back
Warby Parker Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
WRBY
Warby Parker
Last Price:
23.09
Seasonality Move:
-10.91%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
34.33%
Buy
64
Warby Parker (WRBY)
is a Buy
Is Warby Parker a Buy, Sell or Hold?
- The current Warby Parker [WRBY] share price is $23.11. The Score for WRBY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- WRBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WRBY Stock Price Chart
What is Warby Parker's stock price today?
-
The Warby Parker share price today is $23.11
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WRBY is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.47
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.
WRBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.74 | Buy |
| Relative Strength Index (14 RSI): | 83.01 | Buy |
| Chaikin Money Flow: | -545582 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.23 - 21.83) | Buy |
| Bollinger Bands (100): | (13.86 - 18.64) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.06 | Sell |
| Relative Strength Index (14 RSI): | 14.31 | Sell |
| Chaikin Money Flow: | 5909257 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.39 - 12.93) | Sell |
| Bollinger Bands (100): | (10.25 - 14.79) | Sell |
WRBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.43 | Buy |
| 20-day SMA: | 20.03 | Buy |
| 50-day SMA: | 17.54 | Buy |
| 200-day SMA: | 15.24 | Buy |
| 8-day EMA: | 22.37 | Buy |
| 20-day EMA: | 20.6 | Buy |
| 50-day EMA: | 18.37 | Buy |
| 200-day EMA: | 15.77 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.64 | Sell |
| 20-day SMA: | 9.7 | Sell |
| 50-day SMA: | 11.58 | Sell |
| 200-day SMA: | 12.72 | Sell |
| 8-day EMA: | 6.25 | Sell |
| 20-day EMA: | 8.74 | Sell |
| 50-day EMA: | 10.88 | Sell |
| 200-day EMA: | 11.36 | Sell |
Warby Parker Earnings Growth & WRBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.08 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Warby Parker Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||